Lipoprotein-associated phospholipase A2 and risks of coronary heart disease and ischemic stroke in the general population: A systematic review and meta-analysis
D Li, W Wei, X Ran, J Yu, H Li, L Zhao, H Zeng… - Clinica Chimica …, 2017 - Elsevier
Background This study investigated the associations between lipoprotein-associated
phospholipase A2 (Lp-PLA2) and the risks of coronary heart disease (CHD) and ischemic …
phospholipase A2 (Lp-PLA2) and the risks of coronary heart disease (CHD) and ischemic …
Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review
CA Garza, VM Montori, JP McConnell, VK Somers… - Mayo Clinic …, 2007 - Elsevier
OBJECTIVE To estimate the association between plasma lipoprotein-associated
phospholipase A 2 (Lp-PLA 2) levels and cardiovascular disease (CVD). METHODS We …
phospholipase A 2 (Lp-PLA 2) levels and cardiovascular disease (CVD). METHODS We …
[HTML][HTML] Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
Lp-PLA2 Studies Collaboration - The Lancet, 2010 - Elsevier
BACKGROUND: Lipoprotein-associated phospholipase A2 (Lp-PLA2), an inflammatory
enzyme expressed in atherosclerotic plaques, is a therapeutic target being assessed in trials …
enzyme expressed in atherosclerotic plaques, is a therapeutic target being assessed in trials …
Lipoprotein‐associated phospholipase A2 activity and mass as independent risk factor of stroke: A meta‐analysis
G Hu, D Liu, H Tong, W Huang, Y Hu… - BioMed Research …, 2019 - Wiley Online Library
Background. The association between lipoprotein‐associated phospholipase A2 (Lp‐PLA2)
and stroke risk is inconsistent. We conducted a meta‐analysis to determine whether …
and stroke risk is inconsistent. We conducted a meta‐analysis to determine whether …
The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A2: a systematic …
Y Tian, H Jia, S Li, Y Wu, L Guo, G Tan, B Li - Medicine, 2017 - journals.lww.com
Background: Studies on stroke and lipoprotein-associated phospholipase A 2 (Lp-PLA 2)
have produced conflicting results. Objective: The aim of the study was to assess the …
have produced conflicting results. Objective: The aim of the study was to assess the …
Lipoprotein-associated phospholipase A (2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
A Thompson, P Gao, L Orfei, S Watson… - Lancet (London …, 2010 - europepmc.org
Background Lipoprotein-associated phospholipase A (2)(Lp-PLA (2)), an inflammatory
enzyme expressed in atherosclerotic plaques, is a therapeutic target being assessed in trials …
enzyme expressed in atherosclerotic plaques, is a therapeutic target being assessed in trials …
Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis
PK Garg, RL McClelland, NS Jenny, MH Criqui… - Atherosclerosis, 2015 - Elsevier
Objective Prospective studies reporting a positive association of lipoprotein-associated
phospholipase A 2 (Lp-PLA 2) mass and activity with incident cardiovascular disease (CVD) …
phospholipase A 2 (Lp-PLA 2) mass and activity with incident cardiovascular disease (CVD) …
Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study
HHS Oei, IM Van Der Meer, A Hofman, PJ Koudstaal… - Circulation, 2005 - Am Heart Assoc
Background—Lipoprotein-associated phospholipase A2 (Lp-PLA2) has been proposed as
an inflammatory marker of cardiovascular disease. In the present study, we investigated …
an inflammatory marker of cardiovascular disease. In the present study, we investigated …
Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse …
ES Brilakis, JP McConnell, RJ Lennon… - European heart …, 2005 - academic.oup.com
Aims We aimed to evaluate the association of lipoprotein-associated phospholipase A2 (Lp-
PLA2) with coronary artery disease (CAD) risk factors, with the severity of angiographic …
PLA2) with coronary artery disease (CAD) risk factors, with the severity of angiographic …
Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker
O Vittos, B Toana, A Vittos, E Moldoveanu - Biomarkers, 2012 - Taylor & Francis
Objective: To conduct a comprehensive, systematic review of studies assessing the
significance of lipoprotein-associated phospholipase A2 in cardiovascular diseases (CVDs) …
significance of lipoprotein-associated phospholipase A2 in cardiovascular diseases (CVDs) …